VDR and leukemia: These findings might suggest a role for the VDR to be mutated or deleted in leukemia and although there were numerous candidate studies of the VDR expression and genomic integrity, large-scale genomic approaches, for example in the TCGA leukemia cohort [40], suggest that the VDR is neither distorted to act as cancer-driver, nor has it been therapeutically exploited to date.